The knowledge accumulated over the past two decades has revealed that the natural history of metabolic dysfunction-associated steatotic liver disease (MASLD) and the drivers of the disease severity are not only complex but also exhibit variation among patients. This intricate clinical scenario entails major therapeutic and management implications. In this review, we provide a comprehensive examination of recent advancements in our understanding of MASLD heterogeneity, drawing insights from multiomics and panomics studies. The discussion herein explores the instrumental role of panomics in MASLD research, elucidating the potential for the identification of molecular subtypes that exhibit divergent survival outcomes or heterogeneous responses to various treatments. Furthermore, we provide insights into the challenges in addressing disease heterogeneity and potential solutions. Finally, the most advanced technological advancements and prospective research directions in the domain of MASLD research are delineated, with the objective of facilitating the implementation of personalized diagnosis and interventions.
Navigating liver health with metabolomics: A comprehensive review Preetpal Singh, Ravinder Singh, Chirag Pasricha, Pratima Kumari Clinica Chimica Acta.2025; 566: 120038. CrossRef
Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications” Soon Kyu Lee, Jong Young Choi Clinical and Molecular Hepatology.2025; 31(1): 301. CrossRef
Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications” Satya Priya Sharma, Ki Tae Suk Clinical and Molecular Hepatology.2025; 31(1): e74. CrossRef
Hepatoprotective Effects of Citri reticulatae Pericarpium and Chaenomelese speciosa (Sweet) Nakai Extracts in Alcohol-Related Liver Injury: Modulation of Oxidative Stress, Lipid Metabolism, and Gut Microbiota Shuangshuang Ma, Lingtao Kang, Zhipeng Gao, Zhaoping Pan, Lvhong Huang, Jiaxu Chen, Yanfang Liao, Jiajing Guo, Fuhua Fu Antioxidants.2025; 14(3): 343. CrossRef
Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease Raja Ganesan, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Sang Hak Han, Young Joo Yang, Gwang Ho Baik, Chang Seok Bang, Dong Joon Kim, Ki Tae Suk Hepatology International.2024; 18(2): 486. CrossRef
Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis Min Woo Kang, Soon Kyu Lee, Eun Ji Jang, Jong Geun Park, Deok Hwa Seo, Ji Won Han, Jae Sung Yoo, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung Liver Transplantation.2024; 30(9): 877. CrossRef
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients—Authors' reply Jun Sik Yoon, Jeong‐Hoon Lee Alimentary Pharmacology & Therapeutics.2024; 60(4): 546. CrossRef
Therapeutic effects of fecal microbial transplantation on alcoholic liver injury in rat models Yue Zhang, Pengfei Li, Bo Chen, Ruipeng Zheng Clinics and Research in Hepatology and Gastroenterology.2024; 48(9): 102478. CrossRef
Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun Scientific Reports.2024;[Epub] CrossRef
Rice Protein Peptides Alleviate Alcoholic Liver Disease via the PPARγ Signaling Pathway: Through Liver Metabolomics and Gut Microbiota Analysis Yue Tian, Yangzheng He, Hua Xiong, Yong Sun Journal of Agricultural and Food Chemistry.2024; 72(43): 23790. CrossRef
Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury Zufeng Wang, Chengliang Luo, Edward W. Zhou, Aaron F. Sandhu, Xiaojing Yuan, George E. Williams, Jialu Cheng, Bharati Sinha, Mohammed Akbar, Pallab Bhattacharya, Shuanhu Zhou, Byoung-Joon Song, Xin Wang International Journal of Molecular Sciences.2023; 24(10): 8805. CrossRef
Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease Raja Ganesan, Ki Tae Suk Livers.2022; 2(3): 139. CrossRef
Diagnostic and molecular portraits of microbiome and metabolomics of short-chain fatty acids and bile acids in liver disease Raja Ganesan, Ki Tae Suk Process Biochemistry.2022; 123: 70. CrossRef
First
Prev
